4 ML sodium hyaluronate 22 MG/ML Prefilled Syringe [Monovisc]
RxNorm concept 1537107, branded drug (sbd). Prescribable name: Monovisc 22 MG/mL in 4 mL Prefilled Syringe.
- RxCUI
- 1537107
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1537107 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Monovisc (as hyaluronan 88 MG per 5 ML) Prefilled Syringe; Monovisc (as hyaluronic acid 88 MG per 4 ML) Prefilled Syringe; Monovisc 88 MG per 4 ML Prefilled Syringe
Related concepts
- sodium hyaluronate 22 MG/ML (SCDC, consists of)
- sodium hyaluronate 22 MG/ML [Monovisc] (SBDC, consists of)
- Prefilled Syringe (DF, has dose form)
- Monovisc (BN, has ingredient)
- 4 ML sodium hyaluronate 22 MG/ML Prefilled Syringe (SCD, tradename of)
Linked data
NDCs
- 59676082001
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1537107 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1537107 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1537107. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.